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Abstract
Objectives: This International League Against Epilepsy (ILAE) Report: (a) summa-
rizes the literature about “driving and psychogenic nonepileptic seizures (PNES)”; 
(b) presents the views of international experts; and (c) proposes an approach to as-
sessing the ability of persons with PNES (PwPNES) to drive.
Methods: Phase 1: Systematic literature review. Phase 2: Collection of interna-
tional expert opinion using SurveyMonkey®. Experts included the members of 
the ILAE PNES Task Force and individuals with relevant publications since 2000. 
Phase 3: Joint analysis of the findings and refinement of conclusions by all par-
ticipants using email. As an ILAE Report, the resulting text was reviewed by the 
Psychiatry Commission, the ILAE Task Force on Driving Guidelines, and Executive 
Committee.
Results: Eight studies identified by the systematic review process failed to provide 
a firm evidence base for PNES-related driving regulations, but suggest that most 
health professionals think restrictions are appropriate. Twenty-six experts responded 
to the survey. Most held the view that decisions about driving privileges should 
consider individual patient and PNES characteristics and take account of whether 
permits are sought for private or commercial driving. Most felt that those with active 
PNES should not be allowed to drive unless certain criteria were met and that PNES 
should be thought of as “active” if the last psychogenic seizure had occurred within 
6 months.
Significance: Recommendations on whether PwPNES can drive should be made at 
the individual patient level. Until future research has determined the risk of accidents 
in PwPNES a proposed algorithm may guide decisions about driving advice.
K E Y W O R D S
driving, nonepileptic, PNES, psychogenic, seizure
1 |  INTRODUCTION
Psychogenic nonepileptic seizures (PNES), also known as 
dissociative seizures/ attacks/ events/ episodes, are defined 
by their superficial semiological resemblance to epileptic 
seizures or syncope, although the manifestations of PNES 
are not explained by epileptic discharges or other readily 
observable physiological changes. Instead, most PNES are 
thought to be non-volitional responses to internal or ex-
ternal triggers perceived as threatening or challenging.1,2 
While patients with PNES do not fit into a single category 
of the current international nosologies of mental disorders, 
most who are given this label fulfill the diagnostic crite-
ria of Functional Neurological Symptom (Conversion) 
Disorder (DSM-5) or Dissociative Seizure Disorder 
(ICD11).3 The incidence of PNES has been observed to 
be 1.4-4.9/100  000/year and the prevalence estimated as 
up to 33 per 100 000 of the general population. As such, 
PNES are one of the three most common diagnoses made 
when patients present to seizure clinics. Given that this 
condition most commonly affects young adults,1 questions 
about driving a motor vehicle safely and PNES often arise 
in clinical practice.
Most patients diagnosed with PNES self-report loss of 
responsiveness or loss of awareness in their events.4,5 Self-
reported loss of responsiveness in PNES is significantly asso-
ciated with self-reported seizure-related injuries [odds ratio 
(OR): 3.5; 95% confidence interval (CI): 1.4-8.7].4 Drivers 
with neurological conditions have been found to be more 
likely to cause road traffic accidents compared to controls 
(OR: 5.2; 95% CI: 2.6-10.3), as have drivers with psychiat-
ric disorders (OR: 3.6; 95% CI: 1.9-6.9).6 These observations 
mean that it is plausible that drivers with PNES could be at 
increased risk of causing driving-related accidents. However, 
in the absence of data proving an increased PNES-associated 
risk, compulsory driving suspension may be inappropriate, 
given that loss of driving privileges can have a major neg-
ative impact on patients' quality of life, ability to socialize, 
and socioeconomic status.7–9 The fundamental challenge lies 
in identifying an appropriate balance between the safety of 
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patients with PNES and the public on the one hand, and the 
independence, autonomy, and quality of life of patients with 
PNES, on the other hand.
Given that there are currently no widely agreed practice 
guidelines on how to counsel patients with PNES on driv-
ing, our aims were to (a) review the literature about driving 
a motor vehicle and PNES; (b) gather the views of an inter-
national group of experts in the field on the issue of driving 
a motor vehicle and PNES; and, (c) summarize the findings 
and propose guidance on decisions about driving advice for 
individuals with PNES (single or recurrent) based on the ma-
jority views of the contributing experts.
2 |  METHODS
2.1 | Phase 1 (systematic literature review)
We searched MEDLINE (accessed through PubMed) for ar-
ticles published before July 5, 2019, that included any of the 
search terms selected (non-epileptic seizures, nonepileptic 
seizures, pseudoseizures, non-epileptic events, nonepilep-
tic events, pseudoepileptic seizures, psychogenic seizures, 
psychogenic events, psychogenic non-epileptic attacks, psy-
chogenic nonepileptic attacks, psychogenic non-epileptic 
episodes, psychogenic nonepileptic episodes, dissociative 
seizures, psychogenic non-epileptic seizures, psychogenic 
nonepileptic seizures, PNES, and hysterical seizures) AND 
“driving” (Appendix 1), in their abstracts and titles. Review 
articles on PNES and articles not written in English were 
excluded. We selected the relevant articles by first screen-
ing titles and abstracts and subsequently reading in full any 
articles that appeared to contain information addressing 
the issue of driving in patients with PNES. We applied the 
same strategy to search abstracts, titles, and keywords using 
Scopus. We also searched PsycINFO (with “driving” in any 
field and the other keywords in the title). Duplicate and ir-
relevant articles were excluded, and the quality of the evi-
dence was rated. Classes of evidence were categorized using 
the American Academy of Neurology's criteria for studies 
of causation (Appendix 2).10 Reporting complied with the 
PRISMA (Preferred Reporting Items for Systematic reviews 
and Meta-Analyses) statement.11
2.2 | Phase 2 (collection of expert opinions)
On July 11, 2019, we emailed a questionnaire (using 
SurveyMonkey®) designed by AAP, TN, SP, and MR (the 
first three and the last authors) to 50 international experts in 
this field (including these four authors). An email reminder 
was sent five days later. The experts were selected by the 
first three and the last two authors on the basis of meeting the 
following criteria: all members of the International League 
Against Epilepsy (ILAE)-PNES Task Force, authors with 
five or more publications on PNES since 2000 (as the first 
author), authors of the previous original research articles 
on the topic of “driving and PNES”, and board members of 
the Functional Neurological Disorders Society (www.fndso 
ciety.org) with a particular interest in this topic. The survey 
included 10 questions (Appendix 3): one question about pro-
fessional qualifications (1), three questions on the partici-
pants' personal experience with the issue of interest (2, 4, and 
9), five questions probing their opinions about the matter of 
interest (3, and 5-8), and a final question about the respond-
ent's interest in participation in the refinement process of 
the driving decision-making guidance (10). The survey was 
closed on July 23, 2019. The first three and last two authors 
collected and analyzed the responses and developed a first 
draft of a summary based on the results of the review and 
the electronic survey (phases 1 and 2). A “majority opin-
ion” was defined as one endorsed by more than 50% of the 
respondents.
2.3 | Phase 3 (procedure for generating an 
expert opinion statement)
In a series of follow-up email communications (total num-
ber of emails exchanged: 180), all participants who were 
interested in developing an opinion manuscript (n = 23) re-
viewed the initial draft. This draft included a report of the 
participants' responses to the survey. The draft was revised 
and improved by the panel through multiple rounds of email 
correspondence between the co-authors.
In order to resolve issues that had arisen during this 
discussion, a second SurveyMonkey® online questionnaire 
was created and distributed to the 23 participating experts 
(Appendix 4). A final opinion document with a flow dia-
gram intended to support decision-making processes relat-
ing to PNES and driving was prepared, underwent further 
revision, and was ultimately approved by all the partici-
pants in phase 3. There was no face-to-face meeting; the 
Key Points
• There is a lack of high-quality evidence character-
izing accident risks of drivers with PNES
• Expert opinion holds that it is generally appropri-
ate to recommend driving restrictions for individ-
uals with active PNES
• Experts identified a number of PNES features that 
may be compatible with safe private (non-com-
mercial) driving
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T A B L E  1  Details of the original research articles discussing driving in patients with psychogenic nonepileptic seizures (PNES)
1st author/Year/Country Study type Methods Results
Class of 
evidence
Benbadis/ 2000/ USA Survey & cross-
sectional study
Survey of 37 physician-members of the American Epilepsy 
Society & study of a population of 20 patients with PNES, 
comparing driving records over a 5-year period with general 
population accident rates.
49% of survey respondents applied the same restrictions for 
PNES as for epilepsy; 32% did not place patients with PNES 
under any restrictions; 19% decided on a case-by-case basis.
The retrospective study of 20 PwPNES captured a total of 
8 accidents, with no fatal crashes. The accident rate in this 
population did not exceed that in the general population.
IV
Specht/2009/Germany Survey Email survey of 34 German epileptologists. Same restrictions as stipulated for patients with epilepsy 
endorsed by 32.4% of respondents; no restrictions at all by 0%; 
decision on an individualized basis by 67.6%.
IV
Morrison/2011/ UK Survey 54 members of the Association of British Neurologists 68% of epilepsy specialists recommended driving restrictions 
for PNES. Two respondents reported patients with PNES-
related motor accidents.
IV
Sahaya/2012/ USA Survey Questionnaire study of 115 healthcare professionals exploring 
views about PNES
Only 15% of the participants favored unrestricted driving by 
patients with PNES in those with active seizure disorders.
IV
Jirsch/2015/ Canada Cross-sectional Patients attending a rapid-referral first seizure clinic were 
entered into the study if they held a valid driver's licence 
and were considered medically unfit to drive according 
to national guidelines for driving licensure due to having 
experienced a seizure or an unexplained episode of lost 
consciousness.
106 of 192 (55%) patients attending clinic met guideline criteria 
requiring driver fitness counseling. 89 patients (46%) were 
considered medically unfit to drive following initial specialist 
consultation. Among those considered medically unfit to drive, 
73% were ultimately thought to have experienced an epileptic 
seizure and 27% a non-epileptic event (eg, syncope, PNES).
IV
Vaidya-Mathur/2016/ USA Survey 141 patients with PNES completed a questionnaire to assess 
their socialization practices and perceived barriers to 
socialization.
Driving prohibition was the most commonly endorsed barrier to 
socializing.
IV
Mahmud/2017/ USA Survey 41 neurologists were surveyed about the length of their 
recommended driving restrictions for patients with suspected 
seizures.
The majority recommended driving restriction of <12 mo for 
PNES.
IV
Farooq/2018/ USA Survey 75 electronic questionnaires were sent to neurologists and 
family medicine physicians to assess their opinion regarding 
driving risk in PNES.
8.3% endorsed a belief that these patients should drive without 
restrictions. 93% felt having guidelines would help them assess 
the driving risk in this population.
IV
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process was accomplished exclusively by email correspon-
dence and draft revisions. This document underwent fur-
ther review by the Psychiatry Commission, Task Force on 
Driving Regulations, Publication Council, and Executive 
Committee of the ILAE prior to submission of the manu-
script for publication.
In thinking about an appropriate driving safety assess-
ment paradigm, we deliberately focused on PNES. Clearly, 
decisions about driving privileges must take account of all 
aspects of the person's health, which could affect their abil-
ity to control a motor vehicle. This is particularly relevant 
in a condition such as PNES, which is commonly associ-
ated with comorbidities including epilepsy or other mental 
health disorders, and in which patients may take medica-
tions that could affect their ability to drive (such as seda-
tive, antiepileptic, antidepressant, or antipsychotic drugs). 
Therefore, while features such as taking medication(s) 
that significantly impair driving ability and having active 
suicidal intent may be regarded as reasons for restricting 
driving privileges, these are not specific to PNES and are 
applicable to all patients with any medical or psychiatric 
condition. Importantly, the specific focus of the current 
paper on PNES means that the suggestions made here al-
ways need to be considered together with any additional 
driving restrictions related to other causes (such as epi-
lepsy) which should—if appropriate—also be applied when 
decisions are made about a patient's fitness to drive. In any 
case, in which greater or more prolonged restrictions apply 
for other reasons than PNES, these more extensive driving 
restrictions should apply in full.
3 |  RESULTS
3.1 | Phase 1
The search strategy yielded eleven relevant articles in 
PubMed7,12–21 and four articles in Scopus22–25 (three were 
reviews and not in English, and one was a review article in 
English). The PsycINFO database search did not yield any 
additional articles (Appendix 1 shows the details of the re-
view process for each keyword in each of the search engines). 
Table 1 describes the methodology, main results, and qual-
ity ratings of the included articles. The manuscripts included 
comprised of seven surveys of patients and healthcare profes-
sionals and one cross-sectional study. A study of 20 patients 
with PNES intended to assess whether they had a higher than 
average risk of car accidents.19 This small study did not find 
an increased risk of motor vehicle accidents among drivers 
with PNES; the accident rate in this population did not ex-
ceed that in the general population.19 The surveys highlight 
that there is controversy of opinions on driving regulations 
in previous studies. An additional seven narrative review ar-
ticles were excluded (Figure 1). None of the eight research 
studies provided class I, II, or III evidence (Table 1).
3.2 | Phase 2
Of the 50 experts approached, 26 responded to the survey 
(response rate: 52%). Respondents were based across five 
continents and eleven countries around the world (Argentina, 
F I G U R E  1  Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses 
(PRISMA) Flow Diagram of the study
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Australia, Brazil, Canada, Georgia, Germany, Iran, Italy, 
South Africa, UK, and USA). Table  2 describes the expe-
riences of the expert participants with patients with PNES. 
Most of the respondents were neurologists and reported 
having extensive clinical experience with PNES (over 200 
patients in their lifetime). Twenty-three percent of the par-
ticipants (n = 6) were aware of at least one patient under their 
care, who had had an accident related to PNES while driv-
ing. However, the total number of patients reported by these 
experts to have had PNES-related driving accidents was only 
eleven, during years of their practice (the total number of 
patients with PNES seen by all experts contributing to this 
report is not known).
Table 3 describes the opinions of the expert participants 
on different aspects of the issue of driving in patients with 
PNES. Only one expert (4%) endorsed the statement that 
“all patients with PNES should be allowed to drive without 
any conditions,” whereas 88% of the experts endorsed that 
“there should be restrictions on driving for some individu-
als with PNES”. In response to “how long do people need 
to be PNES-free before they should not be considered to 
have active PNES?”, most experts (62%) endorsed a three- 
to twelve-month period (mode: six months). Factors spe-
cific to PNES that should prompt the application of driving 
restrictions and that were endorsed by more than 50% of the 
experts included the following: loss of awareness/respon-
siveness with PNES, history of PNES-related injuries, no 
auras or warnings or otherwise predictable seizures, and pa-
tients who want to be commercial drivers. Additional non–
PNES-specific factors endorsed by more than 50% of the 
experts as prompting the need for driving restrictions in-
cluded the following: on medication(s) significantly impair-
ing driving ability and active suicidal intent. Most experts 
believed that an exception from a PNES-related driving 
prohibition could be made in the following circumstances: 
if PNES happen exclusively at times when the person could 
not be driving (eg, at night in bed) and if PNES are always 
preceded by a sufficiently long prodrome allowing the per-
son to pull a car out of traffic and make themselves safe. The 
second survey addressing remaining controversial/ disputed 
topics that was sent to 23 experts was completed by all of 
the initial respondents. Table  4 summarizes the experts' 
opinions captured by this survey. Most experts thought that 
driving restrictions for those seeking commercial driving 
permits should be more restrictive than for those wanting 
to drive privately.
3.3 | Phase 3
Email discussion between the participants of survey one 
yielded further clarifications of the proposal for an individu-
alized driving safety assessment process:
The majority of the experts considered that individuals 
with active PNES should generally not be allowed to drive if 
any of the following criteria are met:
1. Loss of awareness/responsiveness with their psychogenic 
seizures
2. History of PNES-related injuries
3. No auras or warnings or otherwise predictable psycho-
genic seizures
4. If PNES semiology suggests that ability to drive would be 
impaired during a psychogenic seizure.
5. Patients who want to be commercial drivers.
Post-survey email discussions of point 4 yielded the fol-
lowing clarification: Examples would include convulsive or 
thrashing limb movements or visual disturbances. When it 
is uncertain whether the semiology of a psychogenic seizure 
would disrupt driving (eg, brief twitching of left shoulder), 
it is advisable only to consider the semiology as “not dis-
ruptive” if the patient has already had a typical psychogenic 
seizure while driving without experiencing any impairment 
in control of the vehicle or driving ability.
The majority of the experts considered that patients with 
active PNES can be allowed to drive private (non-commer-
cial) vehicles in the following circumstances even if any of 
Number (%)
Discipline of the participants • Neurology: 14 (54)
• Psychiatry: 7 (27)
• Psychology: 3 (12)
• Double board (Neurology & Psychiatry): 2 (8)
Number of patients with PNES 
respondents have managed in 
their lifetime
• More than 200 patients: 15 (58)
• 100-200 patients: 4 (15)
• Less than 100 patients: 7 (27)
Are you aware of a patient with 
PNES under your care, who has 
had an accident while driving 
due to their PNES?
• Yes: 6 (23) (1,1,2, 2, and 5 patients were reported by 
different experts; one participant did not specify a 
number)
• No: 20 (77)
T A B L E  2  Participants' experience 
with patients with psychogenic nonepileptic 
seizures (PNES)
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the above-mentioned criteria are met (active PNES per se is 
not considered a contraindication to driving):
1. If PNES happen exclusively at times when the person 
could not be driving (eg, at night in bed).
2. If psychogenic seizures occur exclusively after expo-
sure to very specific triggers that they could not possi-
bly encounter when driving (eg, confined spaces without 
windows, specific objects, or places acting as traumatic 
reminders).
3. If PNES are always preceded by a sufficiently long pro-
drome allowing the person to pull a car out of traffic and 
make themselves safe. Some patients report a recogniz-
able warning sign (eg, light-headedness and headache, 
etc), which invariably precedes each psychogenic sei-
zure and would always provide enough time (minutes to 
hours) to safely bring the car to a halt. In all other cases, 
psychogenic seizure onset should be considered “sudden 
and unpredictable” when assessing a person's fitness to 
drive.
T A B L E  3  Experts' opinions about driving and psychogenic nonepileptic seizures (PNES)
Number (%)
Should all patients with 
PNES, with or without active 
psychogenic seizures, be allowed 
to drive without any conditions?
• Yes: 1 (4)
• No: 21 (81)
• Not sure: 4 (15)
If all patients with PNES should 
be allowed to drive without 
any conditions, which of the 
following reasons lead you to 
this conclusion? (You may select 
both)
• In my clinical experience, these patients do not have accidents driving: 1 (4)
• I'm not aware of any evidence that patients with PNES are at increased risk of driving accidents: 4 (15)
• Skipped: 21 (81)
If patients with PNES should not 
be allowed to drive, which of 
the following statements do you 
endorse?
• There should be restrictions on driving for some individuals with PNES: 23 (88)
• None of the individuals with active PNES (Patients with seizures) should be allowed to drive: 2 (8)
• Skipped: 1 (4)
If individuals with PNES should 
not be allowed to drive, please 
specify your definition of “active 
PNES”: How long do people 
need to be PNES-free before they 
should be considered not to have 
“active PNES”?
• 1 mo: 2 (8)
• 3 mo: 4 (15)
• 6 mo: 9 (35)
• 12 mo: 3 (12)
• 24 mo: 1 (4)
• More than 24 mo: 0
• Skipped: 7 (27)
If there should be restrictions on 
driving for some individuals with 
PNES, which patients with PNES 
should not be allowed to drive? 
(You can select more than one 
choice)
• Patients with loss of responsiveness (with preserved awareness) with their seizures: 16 (62)
• Patients with loss of consciousness with their seizures: 21 (81)
• Patients with memory gaps with or after their seizures: 7 (27)
• Patients with no auras, warnings or otherwise predictable seizures: 16 (62)
• Patients with prolonged seizures (more than 5 min): 7 (27)
• Patients with motor seizures: 9 (35)
• Patients with akinetic (dialeptic) seizures: 9 (35)
• Patients with history of PNES-related injuries: 17 (65)
• Patients with daily seizures: 10 (38)
• Patients with weekly seizures: 9 (35)
• On medication(s) that significantly impair driving ability: 18 (69)
• Patients who want to be commercial drivers: 14 (54)
• Patients driving with passengers in the car: 7 (27)
• Patients with active suicidal intent: 16 (62)
• Skipped: 1 (4)
Are there any circumstances in 
which patients with PNES should 
be allowed to drive?
• PNES happen exclusively at times when person not driving (eg, at night in bed): 19 (73)
• PNES are always triggered by a factor that would not be encountered in a car (eg, meeting the 
perpetrator of a crime against the person): 12 (46)
• PNES are preceded by a sufficiently long prodrome allowing the person to pull a car out of traffic and 
make themselves safe: 14 (56)
• Skipped: 3 (12)
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Importantly, these exemption criteria from the driving 
prohibition only apply if a patient has a well-established and 
stable PNES pattern (ie, the pattern has been established for 
at least twelve months and there are no other reasons—in-
cluding other types of seizures—why they should not be al-
lowed to drive). These exemption criteria should not apply if 
the situational context or the semiology of the psychogenic 
seizures has varied in a relevant fashion.
3.4 | Definition of “active PNES”
Initial responses to the question how long individuals should 
be considered to have “active PNES” after their last seizure 
ranged from three to twelve months. At the end of the discus-
sion and refinement process (phase 3), the contributing ex-
perts settled, by majority views, on six months, the mode of 
their initial responses. While the uncertainty about this point 
reflects the lack of research on this issue, this means that the 
expert group viewed a period of six months free of PNES as 
a sufficiently long time to lift any restrictions to private driv-
ing imposed in relation to this disorder. However, especially 
reflecting the greater risk to the public associated with com-
mercial driving, it was the view of the majority experts in this 
survey that individuals seeking a commercial driving license 
should have been free of PNES for a much longer period (two 
to five years) before restrictions could be removed, regardless 
of psychogenic seizure semiology or illness features, in order 
to clearly establish that they have overcome this condition.
Ultimately, the expert email discussion of the previous 
literature and current surveys yielded a flow diagram with 
a proposal for a decision-making algorithm for assessments 
about driving safety in individuals with PNES (Figure 2).
4 |  DISCUSSION
While it is possible that some patients with PNES are more 
likely than other members of the general public to be in-
volved in road traffic accidents, there is currently no compel-
ling evidence supporting or refuting this proposition directly. 
One small study of 20 patients suggested that there was no in-
creased risk of motor vehicle accidents among patients with 
PNES,19 but larger scale studies are clearly needed. In one 
survey of health professionals, over 90% of neurologists and 
family medicine physicians endorsed the necessity of guide-
lines for driving safety decisions in patients with PNES.16 In 
the absence of high-quality evidence, an expert opinion state-
ment providing preliminary guidance on this important so-
cial issue may be helpful. This survey and exchange of ideas 
documented variable practices across many epilepsy centers 
and provides basis for future explorations of this topic.
Number (%)
Are there some types of PNES which are 
compatible with driving?
• Yes: 17 (74)a 
• No: 5 (22)
• Skipped: 1 (4)
Do you agree with this statement? “Patients 
with active PNES should not be able to get 
a commercial driving license for a longer 
period (> 12 mo), regardless of seizure 
semiology or illness features.”
• Yes: 14 (61)
• No: 6 (26)
• Other: 3 (13)
For how long does an individual need to be 
PNES-free before they can be considered fit 
to apply for a commercial driver's license?
• 18 mo: 3 (13)
• 2 y: 4 (17)
• 3 y: 3 (13)
• 5 y: 7 (30)
• Other: 5 (22) (two said 12 mo and three 
did not specify)
• Skipped: 1 (4)
What do you think about the length of time 
someone should have had seizures “only in 
situations when person would not be driving 
(eg, at night in bed)” before it is safe to allow 
them to drive?
• 6 mo: 3 (13)
• 12 mo: 13 (57)
• 2 y: 3 (13)
• 3 y: 0
• 5 y: 0
• Others: 4 (17) (variable responses)
What do you mean by "only in situations 
when person not driving"?
• Only at night in bed: 10 (45)
• Other: 13 (55) (various non-driving 
situations such as at home or at school)
aExamples include the following: minor motor or sensory PNES with preserved awareness and responsiveness 
and with no loss of motor control. 
T A B L E  4  Experts' opinions about 
some controversial issues on driving and 
patients with psychogenic nonepileptic 
seizures (PNES) (the second survey)
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The nature of driving restrictions in relation to medical 
conditions and the question of whether these are necessary at 
all continues to be debated.16–19,26 In order to provide a sense 
of perspective, it may be helpful to consider the risk variability 
associated with demographic characteristics. For instance, it is 
recognized that the accident risk of male drivers under the age 
of 25 years is five to seven times greater than the mean acci-
dent risk, although this observation does not mean that mem-
bers of this demographic group are banned from driving.27 
However, in line with previous surveys focusing on PNES, 
the experts contributing to the present project held the view 
that driving restrictions should be recommended, at least for 
some individuals with this disorder. Despite the uncertainties 
and lack of evidence, it seems appropriate to err on the side 
of caution when driving privileges are concerned, especially 
given that the risks associated with driving would not just af-
fect the individuals with PNES themselves. It is likely that the 
risks to others would be even greater in relation to commercial 
than private driving. It could therefore be argued that drivers 
with PNES should demonstrate to the community that they are 
safe to drive.28 Individuals affected might do so by having been 
PNES-free for a period of time before being allowed to drive 
commercially.28 In relation to private (non-commercial) driv-
ing, the panel of experts contributing to this study ultimately 
considered a six-month PNES-free period as reasonable evi-
dence that a PNES disorder is under control. A considerably 
longer period of complete PNES control would be appropriate 
before commercial driving could be allowed.
The perception of PNES as a clinically heterogeneous dis-
order was reflected by the fact that the experts contributing 
F I G U R E  2  Expert proposal for a 
decision-making process about the safety of 
patients with PNES to drive
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to this project felt that, in certain circumstances, exceptions 
could be made from the general rule that patients with active 
PNES should not drive: The majority suggested that private 
(non-commercial) driving should be permissible for individ-
uals with PNES if there is a clearly established pattern of 
PNES happening exclusively at times when the person could 
not be driving, if PNES occur exclusively after exposure to 
very specific triggers that affected individuals could not pos-
sibly encounter when driving, and/or if the individuals al-
ways experience clear warning signs of sufficient duration 
that it would make it feasible for them to pull over their car 
and stop driving safely prior to an event.
The group of individuals with comorbid epilepsy and 
PNES presents a particular diagnostic and treatment chal-
lenge. While the overwhelming majority of patients with 
PNES do not suffer from epileptic seizures, a substantial mi-
nority (around 20%) have comorbid epilepsy.29,30 As long as 
a patient with mixed epilepsy/PNES is experiencing epilep-
tic seizures (or if the treating physician is not sure whether 
the epileptic seizures have stopped), then driving restrictions 
related to epilepsy should be invoked.28 Similarly, patients 
whose seizures are of uncertain etiology and who have not 
received a diagnosis of PNES that is sufficiently certain for 
the treating physician only to recommend treatment for this 
disorder and to stop any erroneously prescribed antiseizure 
medication treatments should be advised to adhere to laws 
restricting driving with epileptic seizures. However, if the 
treating physician firmly concludes that all ongoing seizures 
are due to PNES and that there have been no epileptic sei-
zures for the period of time required by the relevant state law 
relating to epilepsy, then the opinions in this document would 
be applicable.
Changes in semiology represent another important chal-
lenge when exemptions from PNES-related driving restric-
tions have been made. Although PNES semiology has been 
shown to be relatively stable over the short term,31 there is 
evidence that, over the longer term, it is more variable than 
the semiology of epileptic seizures.32,33 This means that the 
suitability of individuals with PNES to drive needs to be re-
viewed at regular intervals. Further, those with active PNES 
who are allowed to drive on the basis of the proposed ex-
ception criteria need to be made aware that they must stop 
driving if the nature of their seizures changes and the criteria 
supporting their exception from driving prohibition are no 
longer met.
We acknowledge that our project has several limitations. 
The most important of these is the lack of sufficient data in-
forming us of the risk of PNES in relation to driving. The 
wording of survey questions and other questions not addressed 
may have influenced the results. For example, our questions 
did not specify whether relevant ictal features should be pa-
tient-reported, witness-supported, or clinician-observed—
these specifications may have had an effect on the results. 
Only a limited number of experts were approached and only 
52% of those participated, raising the possibility that the opin-
ions reflected in this manuscript are not fully representative 
of wider expert opinion. Additionally, there could be patients 
to whom none of the semiological features listed to aid the 
assessment of driving fitness apply, and further clarification 
may be needed on driving recommendations for patients with 
additional functional neurological symptoms, addressing 
concerns regarding phenotypic evolution and the intersection 
of PNES and paroxysmal functional movement disorders. 
Some of the variability in the responses of the experts to our 
survey reflects the fact that there is no universally accepted 
definition of PNES. For instance, some experts hold that 
individuals may experience PNES with exclusively sensory 
symptoms (without impairment of awareness), while others 
would only use this diagnostic label if there was an associ-
ated impairment of consciousness or self-control. If the risk 
of driving with PNES is similar to that observed in the gen-
eral population, then presentations of expert opinion like this 
may, with hindsight, cause unnecessary harm and restriction 
to individuals with this diagnosis. Conversely, the opinions 
may be too optimistic and cause harm by underemphasizing 
the risks. Finally, some countries in the world may already 
have explicit driving regulations for individuals with PNES 
which supersede any recommendations made here in those 
countries [eg, in Australia, there are regulations for driving in 
“seizures and epilepsy,” without specific reference to PNES, 
which may be considered applicable to PNES, however.34 
In the UK, patients with dissociative seizures (PNES) must 
not drive and must notify the Driver and Vehicle Licensing 
Agency (DVLA). Licensing may be considered when the 
driver or applicant has been event free for 3 months35].
However, until it is possible to develop evidence-based 
guidelines based on well-designed case-control and prospec-
tive cohort studies, the present systematic review and synthe-
sis of expert opinion represent a first step to the development 
of an individualized assessment procedure for patients with 
PNES wanting to drive. In order to achieve the goal of pro-
viding evidence-based guidelines, treating physicians should 
collaborate with mental-health professionals, motor vehicle 
licensing authorities, patient groups, caregivers, and others, 
to fully represent the multitude of relevant perspectives on 
this complex issue. We acknowledge in particular that, re-
gardless of medical risk, driving regulations reflect societal 
pressures and legal responsibilities. We recognize that in 
response to a condition where an individual experiences re-
current and apparently unpredictable loss of consciousness, 
there may be a public demand for regulations that are similar 
to those for epilepsy, even if the associated risks were lower. 
In the absence of relevant evidence, expert opinion may em-
power clinicians to make the best possible decisions about 
driving restrictions in relation to PNES using the algorithm 
proposed in Figure 2 based on individual patient features.
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APPENDIX 3
DRIVING IN PNES
1. What is your discipline?
Neurology
Psychiatry
Psychology
Other (please specify)
2. How many patients with PNES have you seen and man-
aged in your lifetime?
More than 200 patients
100 - 200 patients
Less than 100 patients
3. Should ALL patients with PNES, with or without active 
seizures, be allowed to drive without any conditions?
APPENDIX 1
THE SEARCH KEYWORDS INCLUDED “DRIVING” AND THOSE IN THE FIRST COLUMN OF 
THE TABLE
Keywords (AND driving)
Medline (PubMed) (Title/
Abstract)
Scopus (Title/Abstract/
Keywords) PsycINFO
Primary 
hints Relevant articles
Primary 
hints Relevant articles
Primary 
hints Relevant articles
Non-epileptic seizures 14 4 17 6 (5 duplicates) 2 1 (duplicate)
Nonepileptic seizures 6 5 (5 duplicates) 19 9 (9 duplicates) 3 2 (2 duplicates)
Pseudoseizures 2 1 9 4 (4 duplicates) 1 1 (duplicate)
Non-epileptic events 2 1 (duplicate) 3 2 (2 duplicates) 0 0
Nonepileptic events 0 0 2 0 0 0
Pseudoepileptic seizures 1 0 2 1 (duplicate) 0 0
Psychogenic seizures 14 7 (2 duplicates) 24 11 (8 duplicates) 5 3 (3 duplicates)
Psychogenic events 2 1 (duplicate) 5 1 (duplicate) 0 0
Psychogenic non-epileptic attacks 0 0 2 1 (duplicate) 0 0
Psychogenic nonepileptic attacks 0 0 2 0 0 0
Psychogenic non-epileptic episodes 1 1 (duplicate) 1 1 (duplicate) 0 0
Psychogenic nonepileptic episodes 1 1 (duplicate) 3 2 (2 duplicates) 0 0
Dissociative seizures 0 0 4 1 (duplicate) 0 0
Psychogenic non-epileptic seizures 7 3 (3 duplicates) 9 4 (4 duplicates) 2 1 (duplicate)
Psychogenic nonepileptic seizures 5 5 (5 duplicates) 16 10 (10 duplicates) 3 2 (2 duplicates)
PNES 10 7 (6 duplicates) 22 9 (9 duplicates) 1 1 (duplicate)
Hysterical seizures 0 0 1 0 0 0
Total 65 34 (23 duplicates) 141 62 (58 duplicates) 17 11 (11 duplicates)
APPENDIX 2
AMERICAN ACADEMY OF NEUROLOGY CRITERIA FOR CLASSIFICATION OF EVIDENCE 
IN STUDIES OF CAUSATION6
Classification Criteria
I Prospective cohort study with all relevant confounders controlled, masked or objective outcome assessments, and
a) ≤2 primary outcomes,
b) clearly defined inclusion/exclusion criteria
c) ≥80% study completion rate.
II Retrospective cohort study or case-control study meeting all other class I criteria.
III Cohort study or case-control study meeting all class I or II criteria except a, b, or c above.
IV Studies not meeting Class I, II, or III criteria
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Yes
No
Not sure
4. If all patients with PNES should be allowed to drive 
without any conditions, which of the following reasons lead 
you to this conclusion? (You may select both)
In my clinical experience these patients do not have acci-
dents driving
I'm not aware of any evidence that patients with PNES are 
at increased risk of driving accidents
Other (please specify)
5. If patients with PNES should NOT be allowed to drive, 
which of the following statements do you endorse? (Select 
one)
There should be restrictions on driving for some individ-
uals with PNES
None of the individuals with active PNES (Patients with 
seizures) should be allowed to drive
6. If individuals with active PNES should not be allowed to 
drive, please specify your definition of “active PNES”: How 
long do people need to be PNES free before they should not 
be considered to have “active PNES”?
1 month
3 months
6 months
12 months
24 months
More than 24 months
Other (please specify)
7. If there should be restrictions on driving for SOME in-
dividuals with PNES, which patients with PNES should not 
be allowed to drive? (You can select more than one choice)
Patients with loss of responsiveness (with preserved 
awareness) with their seizures
Patients with loss of consciousness with their seizures
Patients with memory gaps with or after their seizures
Patients with no auras, warnings or otherwise predictable 
seizures
Patients with prolonged seizures (more than 5 minutes)
Patients with motor seizures
Patients with akinetic (dialeptic) seizures
Patients with history of PNES-related injuries
Patients with daily seizures
Patients with weekly seizures
On medication(s) that significantly impair driving ability
Patients who want to be commercial drivers
Patients driving with passengers in the car
Patients with active suicidal intent
Other (please specify)
8. Are there any circumstances in which patients with 
PNES should be allowed to drive?
PNES happen exclusively at times when person not driv-
ing (eg, at night in bed)
PNES semiology suggests that ability to drive would be un-
impaired during a seizure (eg, NO loss of responsiveness)
PNES are always triggered by a factor that would not be 
encountered in a car (eg, meeting the perpetrator of a 
crime against the person)
PNES are preceded by a sufficiently long prodrome allowing 
the person to pull a car out of traffic and make themselves safe
Other (please specify)
9. Are you aware of a patient with PNES under your care, 
who has had an accident while driving due to their psycho-
genic seizures?
Yes
No
If yes, how many patients with documented diagnosis of 
PNES with accidents are you aware of?
10. If you are interested in participating in developing the 
expert opinion and manuscript and be a co-author, please 
write your name and best email address below:
APPENDIX 4
SURVEY 2
Are there some types of PNES which are compatible with 
driving?
• Yes (Explain:…)
• No
Do you agree with this statement? “Patients with active 
PNES should not be able to get a commercial driving license 
for a longer period (> 12 months), regardless of seizure semi-
ology or illness features.”
• Yes
• No
• Other (Explain:…)
For how long does an individual need to be PNES-free 
before they can be considered fit to apply for a commercial 
driver's license?
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• 18 months
• 2 years
• 3 years
• 5 years
• Other: …
What do you think about the length of the time someone 
should have had seizures 'only in situations when person not 
driving (eg, at night in bed)' before it is safe to allow them 
to drive?
• 6 months
• 12 months
• 2 years
• 3 years
• 5 years
• Others: …
What do you mean by "only in situations when person not 
driving"?
Only at night in bed
Other:
